Virpax Pharmaceuticals (VRPX) Short Interest Ratio & Short Volume → Historic Crash Could Wipe Away Your 401k (Govt Debt Explosion) (From Birch Gold) (Ad) Free VRPX Stock Alerts $0.72 0.00 (0.00%) (As of 06/11/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Virpax Pharmaceuticals Short Interest DataCurrent Short Interest79,600 sharesPrevious Short Interest7,900 sharesChange Vs. Previous Month+907.59%Dollar Volume Sold Short$62,088.00Short Interest Ratio0.9 Days to CoverLast Record DateMay 15, 2024Outstanding Shares1,170,000 sharesFloat Size1,570,000 sharesShort Percent of Float5.07%Today's Trading Volume11,679 sharesAverage Trading Volume61,627 sharesToday's Volume Vs. Average19% Short Selling Virpax Pharmaceuticals ? Sign up to receive the latest short interest report for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartVRPX Short Interest Over TimeVRPX Days to Cover Over TimeVRPX Percentage of Float Shorted Over Time Ad WealthPressOptions expert shares his top option strategy for freeA 35 year old man from central Florida has stumbled on one of the best strategies we’ve seen in a long time. For the last 30 months his “Friday to Monday” trading strategy has maintained a 71% win rate on more than 350 trades. That includes multiple big time winners like 82% from Adobe… 77% from Palo Alto… But also a barrage of smaller winners like 20% from AMC… Each of which were opened on a Friday afternoon and closed the very next Monday morning. As you’ll see in his brand new video, this strange strategy has given him the ability to capture big time market moves over the weekend.Check it out, simply follow this link here. Virpax Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202479,600 shares $62,088.00 +907.6%5.1%0.9 $0.78 4/30/20247,900 shares $21,409.00 -46.6%0.9%0.3 $2.71 4/15/202414,800 shares $52,248.44 -50.3%1.7%0.6 $3.53 3/31/202429,800 shares $126,983.76 +24.7%3.4%1.3 $4.26 3/15/202423,900 shares $99,663.00 +119.3%2.8%1 $4.17 2/29/202410,900 shares $33,266.80 -82.5%1.3%0.3 $3.05 Get the Latest News and Ratings for VRPX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virpax Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/15/202462,400 shares $22,938.24 -12.2%0.7%0.2 $0.37 1/31/202471,100 shares $23,391.90 +38.1%0.8%0.2 $0.33 1/15/202451,500 shares $13,750.50 -44.1%0.6%0.2 $0.27 12/31/202392,100 shares $29,481.30 +479.3%1.1%0.3 $0.32 12/15/202315,900 shares $6,224.85 -58.4%0.2%0.1 $0.39 11/30/202338,200 shares $15,272.36 -30.3%0.4%0.7 $0.40 11/15/202354,800 shares $40,661.60 -8.8%0.6%2.1 $0.74 10/31/202360,100 shares $42,983.52 +110.1%0.7%2.4 $0.72 10/15/202328,600 shares $23,457.72 -40.3%0.3%1.1 $0.82 9/30/202347,900 shares $38,315.21 +197.5%0.6%2.3 $0.80 9/15/202316,100 shares $12,702.90 -37.6%0.2%0.7 $0.79 8/31/202325,800 shares $22,188.00 -22.8%0.3%0.8 $0.86 8/15/202333,400 shares $29,893.00 -20.1%0.4%1 $0.90 7/31/202341,800 shares $37,202.00 +1.7%0.5%1.3 $0.89 7/15/202341,100 shares $40,278.00 -48.1%0.5%1.3 $0.98 6/30/202379,200 shares $85,536.00 +56.8%0.9%2.6 $1.08 6/15/202350,500 shares $46,460.00 -35.2%0.6%1.8 $0.92 5/31/202377,900 shares $61,143.71 -26.1%0.9%4.2 $0.78 5/15/2023105,400 shares $90,654.54 +22.3%1.2%6.1 $0.86 4/30/202386,200 shares $61,245.10 +2.9%1.0%4.1 $0.71 4/15/202383,800 shares $64,291.36 -7.7%1.0%2.1 $0.77 3/31/202390,800 shares $71,278.00 +7.3%1.0%2.3 $0.79 3/15/202384,600 shares $67,680.00 +6.8%1.0%1.8 $0.80 2/28/202379,200 shares $74,677.68 -40.4%0.9%1.6 $0.94 2/15/2023132,900 shares $145,339.44 +285.2%1.6%2.6 $1.09 1/31/202334,500 shares $34,148.10 +1.8%0.4%0.7 $0.99 1/15/202333,900 shares $28,137.00 -18.9%0.4%0.9 $0.83 12/30/202241,800 shares $26,012.14 -51.1%0.5%1 $0.62 12/15/202285,400 shares $68,320.00 +100.9%1.0%2.3 $0.80 11/30/202242,500 shares $35,700.00 +21.1%0.5%1.2 $0.84 11/15/202235,100 shares $30,105.27 +19.0%0.4%1 $0.86 10/31/202229,500 shares $31,565.00 +16.6%0.3%0.7 $1.07 10/15/202225,300 shares $27,071.00 -39.3%0.3%0.5 $1.07 9/30/202241,700 shares $49,623.00 +37.6%0.5%0.9 $1.19This indicator is great for calling bottoms (Ad)“It was designed to help boost your chances of finding rock solid trade ideas” It’s called the “Master Indicator” And it’s quite possibly one of the most useful indicators you’ll ever use.If you’d like to join me just follow this link here. 9/15/202230,300 shares $39,693.00 +5.6%0.4%0.6 $1.31 8/31/202228,700 shares $36,449.00 -22.9%0.3%0.5 $1.27 8/15/202237,200 shares $62,496.00 -45.7%0.4%0.6 $1.68 7/31/202268,500 shares $104,120.00 +78.9%0.8%0.8 $1.52 7/15/202238,300 shares $62,046.00 -41.1%0.5%0.3 $1.62 6/30/202265,000 shares $109,200.00 -15.1%0.8%0.4 $1.68 6/15/202276,600 shares $107,240.00 -12.6%0.9%0.5 $1.40 5/31/202287,600 shares $124,392.00 -35.0%1.0%0.5 $1.42 5/15/2022134,800 shares $180,632.00 +61.8%1.5%0.8 $1.34 4/30/202283,300 shares $147,441.00 +1.0%1.0%0.5 $1.77 4/15/202282,500 shares $165,825.00 +32.4%0.9%0.6 $2.01 3/31/202262,300 shares $138,306.00 +3.2%0.7%0.4 $2.22 3/15/202260,400 shares $121,404.00 -4.9%0.7%0.3 $2.01 2/28/202263,500 shares $137,795.00 +15.9%0.7%0.1 $2.17 2/15/202254,800 shares $126,588.00 -22.6%0.6%0.1 $2.31 1/31/202270,800 shares $150,804.00 +17.8%0.8%0.1 $2.13 1/15/202260,100 shares $172,487.00 -70.4%0.7%0.1 $2.87 12/31/2021203,000 shares $696,290.00 -30.7%N/A0.2 $3.43 12/15/2021293,000 shares $1.13 million +222.0%3.3%0.3 $3.85 11/30/202191,000 shares $425,880.00 -60.5%1.0%0.1 $4.68 11/15/2021230,100 shares $991,731.00 -3.6%2.6%0.2 $4.31 10/29/2021238,800 shares $998,184.00 +8.2%2.7%0.1 $4.18 10/15/2021220,700 shares $988,736.00 -25.2%2.5%0 $4.48 9/30/2021294,900 shares $1.42 million -11.1%3.3%0.1 $4.80 9/15/2021331,600 shares $2.00 million +35.2%6.8%0.1 $6.02 8/31/2021245,200 shares $4.68 million +103.8%11.9%0 $19.10 8/13/2021120,300 shares $544,959.00 No Change5.8%0 $4.53 VRPX Short Interest - Frequently Asked Questions What is Virpax Pharmaceuticals' current short interest? Short interest is the volume of Virpax Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of May 15th, traders have sold 79,600 shares of VRPX short. 5.07% of Virpax Pharmaceuticals' shares are currently sold short. Learn More on Virpax Pharmaceuticals' current short interest. What is a good short interest ratio for Virpax Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRPX shares currently have a short interest ratio of 1.0. Learn More on Virpax Pharmaceuticals's short interest ratio. What is a good short interest percentage for Virpax Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.07% of Virpax Pharmaceuticals' floating shares are currently sold short. Is Virpax Pharmaceuticals' short interest increasing or decreasing? Virpax Pharmaceuticals saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 79,600 shares, an increase of 907.6% from the previous total of 7,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Virpax Pharmaceuticals' float size? Virpax Pharmaceuticals currently has issued a total of 1,170,000 shares. Some of Virpax Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Virpax Pharmaceuticals currently has a public float of 1,570,000 shares. How does Virpax Pharmaceuticals' short interest compare to its competitors? 5.07% of Virpax Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Virpax Pharmaceuticals: Aptevo Therapeutics Inc. (1.33%), Cyclacel Pharmaceuticals, Inc. (10.61%), Revelation Biosciences, Inc. (1.52%), Sonoma Pharmaceuticals, Inc. (0.48%), Aravive, Inc. (1.81%), Biophytis S.A. (2.62%), Quoin Pharmaceuticals, Ltd. (0.07%), PaxMedica, Inc. (4.65%), Agile Therapeutics, Inc. (12.68%), Seelos Therapeutics, Inc. (4.21%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Virpax Pharmaceuticals stock? Short selling VRPX is an investing strategy that aims to generate trading profit from Virpax Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Virpax Pharmaceuticals? A short squeeze for Virpax Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRPX, which in turn drives the price of the stock up even further. How often is Virpax Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRPX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: APVO Short Squeeze CYCC Short Squeeze REVB Short Squeeze SNOA Short Squeeze ARAV Short Squeeze BPTS Short Squeeze QNRX Short Squeeze PXMD Short Squeeze AGRX Short Squeeze SEEL Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRPX) was last updated on 6/11/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virpax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Virpax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.